Delineation of the innate and adaptive T-cell immune outcome in the human host in response to campylobacter jejuniinfection

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Edwards, Lindsey A ^a   Nistala, Kiran ^a   Mills, Dominic C ^b   Stephenson, Holly N ^a   Zilbauer, Matthias ^a,c   Wren, Brendan W ^b   Dorrell, Nick ^b   Lindley, Keith J ^a   Wedderburn, Lucy R ^a   Bajaj Elliott, Mona ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GENTAMICIN; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; CYTOKINE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIUM ADHERENCE; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CELL ACTIVATION; COLON BIOPSY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFECTION RESISTANCE; INNATE IMMUNITY; INTESTINE EPITHELIUM; MONOCYTE; MUCOSAL IMMUNITY; PROTEIN FAMILY; PROTEIN INDUCTION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; CAMPYLOBACTERIOSIS; CHILD; FEMALE; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INTESTINE MUCOSA; MALE; METABOLISM; MICROBIOLOGY; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER; CAMPYLOBACTER JEJUNI;

ADAPTIVE IMMUNITY; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CHILD; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKINS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; ORGAN CULTURE TECHNIQUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TH1 CELLS; TH17 CELLS;

EID: 78649736644     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015398     Document Type: Article

References (49)

1. Young KT, Davis LM, Dirita VJ (2007) Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol 5: 665-679.
2. Poly F, Guerry P (2008) Pathogenesis of Campylobacter. Curr Opin Gastroenterol 24: 27-31.
3. Gradel KO, Nielsen HL, Schonheyder HC, Ejlertsen T, Kristensen B, et al. (2009) Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 137: 495-501.
4. Vucic S, Kiernan MC, Cornblath DR (2009) Guillain-Barre syndrome: An update. J Clin Neurosci 16: 733-741.
5. Oberhelman RA, Gilman RH, Sheen P, Cordova J, Taylor DN, et al. (2003) Campylobacter transmission in a Peruvian shantytown: a longitudinal study using strain typing of campylobacter isolates from chickens and humans in household clusters. J Infect Dis 187: 260-269.
6. Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, et al. (2009) Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol 4: 189-200.
7. Monteiro MA, Baqar S, Hall ER, Chen YH, Porter CK, et al. (2009) Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylo-bacter jejuni. Infect Immun 77: 1128-1136.
8. Schuller S, Lucas M, Kaper JB, Giron JA, Phillips AD (2009) The ex vivo response of human intestinal mucosa to enteropathogenic Escherichia coli infection. Cell Microbiol 11: 521-530.
9. MacCallum AJ, Harris D, Haddock G, Everest PH (2006) Campylobacter jejuni-infected human epithelial cell lines vary in their ability to secrete interleukin-8 compared to in vitro-infected primary human intestinal tissue. Microbiology 152: 3661-3665.
10. Haddock G, Mullin M, Maccallum A, Sherry A, Tetley L, et al. (2010) Campylobacter jejuni 81-176 forms distinct microcolonies on in vitro infected human small intestinal tissue prior to biofilm formation. Microbiology Jul 8, [Epub ahead of print].
11. Rescigno M, Di SA (2009) Dendritic cells in intestinal homeostasis and disease. J Clin Invest 119: 2441-2450.
12. Rathinam VA, Appledorn DM, Hoag KA, Amalfitano A, Mansfield LS (2009) Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through TLR4-MyD88 and TLR4-TRIF axes. Infect Immun 77: 2499-507.
13. Hu L, Bray MD, Osorio M, Kopecko DJ (2006) Campylobacter jejuni induces maturation and cytokine production in human dendritic cells. Infect Immun 74: 2697-2705.
14. Kuijf ML, Samsom JN, van RW, Bax M, Huizinga R, et al. (2010) TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation. J Immunol 185: 748-755.
15. Awasthi A, Kuchroo VK (2009) Th17 cells: from precursors to players in inflammation and infection. Int Immunol 21: 489-498.
16. Goriely S, Neurath MF, Goldman M (2008) How microorganisms tip the balance between interleukin-12 family members. Nat Rev Immunol 8: 81-86.
17. Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, et al. (2008) Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29: 958-970.
18. Wolk K, Witte E, Witte K, Warszawska K, Sabat R (2010) Biology of interleukin-22. Semin Immunopathol 32: 17-31.
19. Gurney AL (2004) IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues. Int Immunopharmacol 4: 669-677.
20. Ma HL, Liang S, Li J, Napierata L, Brown T, et al. (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118: 597-607.
21. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H (2009) Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 10: 864-871.
22. Fox JG, Rogers AB, Whary MT, Ge Z, Taylor NS, et al. (2004) Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect Immun 72: 1116-1125.
23. Lippert E, Karrasch T, Sun X, Allard B, Herfarth HH, et al. (2009) Gnotobiotic IL-10; NF-kappaB mice develop rapid and severe colitis following Campylo-bacter jejuni infection. PLoS One 4: e7413.
24. Dorrell N, Wren BW (2007) The second century of Campylobacter research: recent advances, new opportunities and old problems. Curr Opin Infect Dis 20: 514-518.
25. Moe KK, Mimura J, Ohnishi T, Wake T, Yamazaki W, et al. (2010) The mode of biofilm formation on smooth surfaces by Campylobacter jejuni. J Vet Med Sci 72: 411-416.
26. Beaurepaire C, Smyth D, McKay DM (2009) Interferon-gamma regulation of intestinal epithelial permeability. J Interferon Cytokine Res 29: 133-144.
27. Zilbauer M, Dorrell N, Boughan PK, Harris A, Wren BW, et al. (2005) Intestinal innate immunity to Campylobacter jejuni results in induction of bactericidal human beta-defensins 2 and 3. Infect Immun 73: 7281-7289.
28. Kao CY, Chen Y, Thai P, Wachi S, Huang F, et al. (2004) IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 173: 3482-3491.
29. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, et al. (2009) Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
30. Ouyang W, Kolls JK, Zheng Y (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28: 454-467.
31. Kubota K (2010) Innate IFN-gamma production by subsets of natural killer cells, natural killer T cells and gammadelta T cells in response to dying bacterial-infected macrophages. Scand J Immunol 71: 199-209.
32. Colonna M (2009) Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31: 15-23.
33. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, et al. (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464: 1371-1375.
34. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M (2009) Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31: 321-330.
35. Godinez I, Raffatellu M, Chu H, Paixao TA, Haneda T, et al. (2009) Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype Typhimurium in the intestine. Infect Immun 77: 387-398.
36. Kamada N, Hisamatsu T, Okamoto S, Chinen H, Kobayashi T, et al. (2008) Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest 118: 2269-2280.
37. Ciccia F, Bombardieri M, Principato A, Giardina A, Tripodo C, et al. (2009) Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum 60: 955-965.
38. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, et al. (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463.
39. Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, et al. (2009) Late developmental plasticity in the T helper 17 lineage. Immunity 30: 92-107.
40. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, et al. (2010) Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A 107: 14751-14756.
41. Liang SC, Long AJ, Bennett F, Whitters MJ, Karim R, et al. (2007) An IL-17F/ A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol 179: 7791-7799.
42. Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, et al. (2009) Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30: 108-119.
43. Tecle T, White MR, Gantz D, Crouch EC, Hartshorn KL (2007) Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses. J Immunol 178: 8046-8052.
44. Watson RO, Galan JE (2008) Campylobacter jejuni survives within epithelial cells by avoiding delivery to lysosomes. PLoS Pathog 4: e14.
45. Hicks S, Candy DC, Phillips AD (1996) Adhesion of enteroaggregative Escherichia coli to pediatric intestinal mucosa in vitro. Infect Immun 64: 4751-4760.
46. Dixon GL, Newton PJ, Chain BM, Katz D, Andersen SR, et al. (2001) Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria. Infect Immun 69: 4351-4357.
47. Karlyshev AV, McCrossan MV, Wren BW (2001) Demonstration of polysaccharide capsule in Campylobacter jejuni using electron microscopy. Infect Immun 69: 5921-5924.
48. Nistala K, Moncrieffe H, Newton KR, Varsani H, Hunter P, et al. (2008) Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 58: 875-887.
49. Zilbauer M, Dorrell N, Elmi A, Lindley KJ, Schuller S, et al. (2007) A major role for intestinal epithelial nucleotide oligomerization domain 1 (NOD1) in eliciting host bactericidal immune responses to Campylobacter jejuni. Cell Microbiol 9: 2404-2416.